Migraine Nasal Spray Market Share

  • Report ID: 4059
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Migraine Nasal Spray Market Share

North America Market Statistics

Regionally, the global migraine nasal spray market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America industry is anticipated to hold largest revenue share by 2037, impelled by increasing cases of migraine, raising awareness, and developing health care infrastructure. According to the report published in U.S. National Library for Medicine, migraine continues to be an important public health problem prevalent among 15.9% of all adults in the year 2018. Moreover, around 40% of US adults with migraine were unemployed in the same year. Hence, the governments in developed nations are addressing the disadvantages of migraines and making people aware of remedies, such as, migraine nasal spray, which is estimated to boost the market growth.

APAC Market Analysis

The migraine nasal spray market in the Asia Pacific region is expected to expand significantly over the forecast period. Highly populated countries such as India, China, and others, are estimated to offer a large consumer base for migraine nasal sprays, owing to the increasing cases of migraine in the region.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4059
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of migraine nasal spray is estimated at USD 567.33 million.

Migraine Nasal Spray Market size was valued at USD 536.33 million in 2024 and is likely to cross USD 1.26 billion by 2037, registering more than 6.8% CAGR during the forecast period i.e., between 2025-2037.

North America industry is anticipated to hold largest revenue share by 2037, impelled by increasing cases of migraine, raising awareness, and developing health care infrastructure.

The major players in the market are Upsher-Smith Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Cipla Inc, Dr. Reddy’s Laboratories Ltd, Assertio Therapeutics, Inc., and Impel Neuro Pharma. Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample